November 2, 2021 — Prelude Corporation, a leader in molecular diagnostics and precision medicine for early-stage breast cancer, presented data in an oral scientific session presentation at the American Society for Radiation Oncology (ASTRO) 63rd Annual Meeting held Oct.24 – 27, 2021, at McCormick Place West in Chicago, IL.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now